Skip to content

Date Fruit Benefits to Treat Morning Sickness in First Trimester of Pregnancy

Evaluation of Benefits of Date Fruit in the First Trimester of Pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07354529
Enrollment
40
Registered
2026-01-21
Start date
2025-06-15
Completion date
2026-02-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Pregnancy, Dates, Vomiting, Haemoglobin, Morning Sickness of pregnancy, Hyperemesis gravidarum

Brief summary

The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating morning sickness of pregnancy in pregnant females. The main question\[s\] it aims to answer \[is/are\]: The goal of this randomized clinical trial is to evaluate role of date fruit in The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating vomiting due to morning sickness of pregnancy and in improving maternal hemoglobin in pregnant females. The main question\[s\] it aims to answer \[are\]: * Role of date fruit in alleviating severity and frequency of vomiting due to morning sickness of pregnancy in pregnant females. * Role of date fruit in improving haemoglobin levels in pregnant females. * To assess improvement of severity and frequency of vomiting due to morning sickness of pregnancy and improvement of hemoglobin levels in pregnant females, researchers will compare date fruit intake with antiemetic medication doxylamine succinate 10 mg + pyridoxine HCl 10 and diet only.

Detailed description

A randomized Controlled trial to assess benefits of date fruit in morning sickness of pregnancy symptoms, inclusive of nausea and vomiting and to improve haemoglobin levels in pregnant females.

Interventions

3 Dates after breakfast

DRUGDoxylamine succinate 10 mg + Pyridoxine HCl 10 mg

Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg , One per day

OTHERDiet

Avoidance of high in fat foods and enhanced intake of hydrating fruits and vegetables

Sponsors

Bahria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant females in 18 to 45 year old age group

Exclusion criteria

1. Females in 18 to 45 year old age group who are not pregnant. 2. Females less than 18 years old. 3. Females over 45 years.

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin12 WeeksComplete blood picture (Laboratory diagnostic tests)
Vomiting12 WeeksPUQE-24 Score Unabbreviated scale title : The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24) Minimum Value : 4-6 (Mild) Maximum Value : ≥13 (Severe) Higher Scores mean worst outcome

Secondary

MeasureTime frameDescription
Fatigue level12 weeksFAS Unabbreviated scale title: Fatigue Assessment Scale (FAS) Minimum Value : Less less than 22 Maximum Value : 35 or more indicates severe fatigue Higher Scores mean worst outcome
Dietary Recall12 weeksDirect compliance inquired via telephonic communication on regular basis

Countries

Pakistan

Contacts

PRINCIPAL_INVESTIGATORShehla M Baqai, MBBS, FCPS, FICS

Bahria University Health Sciences Campus Karachi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026